Establishment Labs Holdings ESTA
NASDAQ ESTA
$72.67 +1.15 (+1.61%)
At close: Aug 21, 2026 · 4:00 PM EDT

Establishment Labs Holdings (ESTA) Liabilities and Shareholders Equity (2017 - 2026)

Establishment Labs Holdings (ESTA) posted quarterly Liabilities and Shareholders Equity of $351.0 million for Q1 2026, up 5.3% year-over-year from $333.4 million in Q1 2025, and down 1.72% quarter-over-quarter from $357.2 million in Q4 2025.

Establishment Labs Holdings (ESTA) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $351.0 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 5.3% year-over-year to $351.0 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 10.32% YoY), while the FY2025 annual figure was $357.2 million, up 2.98% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $351.0 million, down from $357.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $357.2 million in Q4 2025, with the low at $141.6 million in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $285.1 million (2024), against an average of $276.5 million.
  • Peak annual rise in Liabilities and Shareholders Equity reached 51.27% in 2022, while the deepest fall reached 7.08% in 2022.
  • Establishment Labs Holdings' Liabilities and Shareholders Equity stood at $211.1 million in 2022, then increased by 27.28% to $268.6 million in 2023, then grew by 29.11% to $346.8 million in 2024, then rose by 2.98% to $357.2 million in 2025, then fell by 1.72% to $351.0 million in 2026.
  • Business Quant data shows ESTA's Liabilities and Shareholders Equity at $351.0 million in Q1 2026, $357.2 million in Q4 2025, and $338.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 109.22 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 13.87 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 31.04 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 10.74 Bn
10 Establishment Labs Holdings 2.20 Bn 2.13 Bn 47.71 Mn 351.93 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 351.93 Mn
Mar 31, 2026 351.04 Mn
Dec 31, 2025 357.17 Mn
Sep 30, 2025 338.90 Mn
Jun 30, 2025 329.67 Mn
Mar 31, 2025 333.36 Mn
Dec 31, 2024 346.83 Mn
Sep 30, 2024 282.69 Mn
Jun 30, 2024 285.09 Mn
Mar 31, 2024 301.84 Mn
Dec 31, 2023 268.64 Mn
Sep 30, 2023 270.53 Mn
Jun 30, 2023 285.30 Mn
Mar 31, 2023 209.36 Mn
Dec 31, 2022 211.06 Mn
Sep 30, 2022 187.65 Mn
Jun 30, 2022 199.88 Mn
Mar 31, 2022 141.56 Mn
Dec 31, 2021 139.53 Mn
Sep 30, 2021 148.36 Mn